Recently, theSARS-CoV-2 Antigen Rapid Test Kit, a COVID-19 antigen detection kit product independently developed by JHOME, was approved by the German Federal Institute for Drugs and Medical Devices (BfArM) to enter the whitelist.
△ Image source: Official website of the German Federal Institute for Drugs and Medical Devices (BfArM)
Relying on professional R&D and innovation strength, JHome has independently developed the SARS-CoV-2 Antigen Rapid Test Kit, which is a more convenient detection operation for individuals and families to conduct self-testing of the COVID-19, allowing more people can quickly get the opportunity to test, cut the chain of infection faster, and prevent the risk of virus transmission.
△JHOME’s SARS-CoV-2 Antigen Rapid Test Kit
After JHOME got the CE certificate. JHome will continue to make greater contributions to the cause of human health with innovative products and services.
